Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20191217045766N1Phase 3Completed
Phase 3 trial of donepezil in opioid use disorder (OUD) (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Opioid craving and Methadone intake. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20191217045766N1.